Gano Kyle bought NBIX
November 1, 2024 · Form 4 insider transaction
Gano Kyle bought 2,455 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,455
Price
$0.00
Total value
N/A
InsiderGano Kyle
Role—
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateNovember 1, 2024
Filing dateNovember 1, 2024
Shares owned after2,455
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock.; The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of November 1, 2025, November 1, 2026, November 1, 2027, and November 1, 2028.